Your browser doesn't support javascript.
loading
No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients.
Philippot, Quentin; Bastard, Paul; Puel, Anne; Casanova, Jean-Laurent; Cobat, Aurélie; Laouénan, Cédric; Tardivon, Coralie; Crestani, Bruno; Borie, Raphael.
Afiliação
  • Philippot Q; Laboratory of Human Genetics of Infectious Diseases, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, Necker Branch, Paris, France.
  • Bastard P; Imagine Institute, University of Paris, Paris, France.
  • Puel A; Laboratory of Human Genetics of Infectious Diseases, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, Necker Branch, Paris, France.
  • Casanova JL; Imagine Institute, University of Paris, Paris, France.
  • Cobat A; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA.
  • Laouénan C; Pediatric Hematology-Immunology and Rheumatology Unit, Necker Hospital for Sick Children, Assistante Publique-Hôpitaux de Paris (AP-HP), Paris, France.
  • Tardivon C; Laboratory of Human Genetics of Infectious Diseases, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, Necker Branch, Paris, France.
  • Crestani B; Imagine Institute, University of Paris, Paris, France.
  • Borie R; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA.
Respir Res ; 24(1): 87, 2023 Mar 20.
Article em En | MEDLINE | ID: mdl-36941652

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Fibrose Pulmonar Idiopática / COVID-19 Tipo de estudo: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Respir Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Fibrose Pulmonar Idiopática / COVID-19 Tipo de estudo: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Respir Res Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França